Search research articles
Contact Us
Filters
Showing results (21-30 of 78) with videos related to
Page
of 8
Sort By:
Therapeutic Drug Monitoring
|
December 25, 2013
The comparison of brand-name and generic formulations of venlafaxine: a therapeutic drug monitoring analysis
Stefan Unterecker, Florian Proft, Peter Riederer, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 17, 2024
Frequencies of <i>CYP2C19</i> and <i>CYP2D6</i> gene variants in a German inpatient sample with mood and anxiety disorders
Maike Scherf-Clavel, Heike Weber, Stefan Unterecker, et al.
Clinical Drug Investigation
|
February 27, 2019
The Combination of Lithium and ACE Inhibitors: Hazardous, Critical, Possible?
Leif Hommers, Matthias Fischer, Christine Reif-Leonhard, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
October 4, 2016
Clinical response in a risperidone-medicated naturalistic sample: patients' characteristics and dose-dependent pharmacokinetic patterns
Michael Paulzen, Ekkehard Haen, Benedikt Stegmann, et al.
Journal of Clinical Psychopharmacology
|
June 3, 2015
Increase of Heart Rate and QTc by Amitriptyline, But Not by Venlafaxine, Is Correlated to Serum Concentration
Stefan Unterecker, Bruno Pfuhlmann, Juliane Kopf, et al.
European Journal of Clinical Pharmacology
|
October 24, 2019
Nortriptyline serum concentration as a predictor for cardiac risk in amitriptyline-treated patients
Maike Scherf-Clavel, Jasper Zebner, Leif Hommers, et al.
Pharmacopsychiatry
|
January 29, 2025
Therapeutic Drug Monitoring of Cariprazine - Updated Values for a Dose-Related Reference Range
Fabian Sattaf, Maike Scherf-Clavel, Stefan Unterecker, et al.
Therapeutic Drug Monitoring
|
June 23, 2020
Therapeutic Drug Monitoring of Antidepressants for the Treatment of Chronic Musculoskeletal Pain With and Without Depression
Maike Scherf-Clavel, Sarah Breisinger, Monika Fischer, et al.
International Clinical Psychopharmacology
|
December 31, 2013
Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine: analysis of therapeutic drug monitoring data under naturalistic conditions
Stefan Unterecker, Andreas Reif, Susanne Hempel, et al.
British Journal of Clinical Pharmacology
|
May 1, 2025
Physiologically based pharmacokinetic modelling predicts altered maternal pharmacokinetics of amitriptyline during pregnancy
Maike Scherf-Clavel, Anna Linda Leutritz, Andrea Gehrmann, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 78) with videos related to
Sort By:
Page
of 8
Therapeutic Drug Monitoring
|
December 25, 2013
The comparison of brand-name and generic formulations of venlafaxine: a therapeutic drug monitoring analysis
Stefan Unterecker, Florian Proft, Peter Riederer, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|
March 17, 2024
Frequencies of <i>CYP2C19</i> and <i>CYP2D6</i> gene variants in a German inpatient sample with mood and anxiety disorders
Maike Scherf-Clavel, Heike Weber, Stefan Unterecker, et al.
Clinical Drug Investigation
|
February 27, 2019
The Combination of Lithium and ACE Inhibitors: Hazardous, Critical, Possible?
Leif Hommers, Matthias Fischer, Christine Reif-Leonhard, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
October 4, 2016
Clinical response in a risperidone-medicated naturalistic sample: patients' characteristics and dose-dependent pharmacokinetic patterns
Michael Paulzen, Ekkehard Haen, Benedikt Stegmann, et al.
Journal of Clinical Psychopharmacology
|
June 3, 2015
Increase of Heart Rate and QTc by Amitriptyline, But Not by Venlafaxine, Is Correlated to Serum Concentration
Stefan Unterecker, Bruno Pfuhlmann, Juliane Kopf, et al.
European Journal of Clinical Pharmacology
|
October 24, 2019
Nortriptyline serum concentration as a predictor for cardiac risk in amitriptyline-treated patients
Maike Scherf-Clavel, Jasper Zebner, Leif Hommers, et al.
Pharmacopsychiatry
|
January 29, 2025
Therapeutic Drug Monitoring of Cariprazine - Updated Values for a Dose-Related Reference Range
Fabian Sattaf, Maike Scherf-Clavel, Stefan Unterecker, et al.
Therapeutic Drug Monitoring
|
June 23, 2020
Therapeutic Drug Monitoring of Antidepressants for the Treatment of Chronic Musculoskeletal Pain With and Without Depression
Maike Scherf-Clavel, Sarah Breisinger, Monika Fischer, et al.
International Clinical Psychopharmacology
|
December 31, 2013
Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine: analysis of therapeutic drug monitoring data under naturalistic conditions
Stefan Unterecker, Andreas Reif, Susanne Hempel, et al.
British Journal of Clinical Pharmacology
|
May 1, 2025
Physiologically based pharmacokinetic modelling predicts altered maternal pharmacokinetics of amitriptyline during pregnancy
Maike Scherf-Clavel, Anna Linda Leutritz, Andrea Gehrmann, et al.
Page
of 8